NDC Package 49281-722-10 Flublok Quadrivalent Northern Hemisphere

Influenza A Virus A/wisconsin/588/2019 (h1n1) Recombinant Hemagglutinin Antigen,Influenza - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
49281-722-10
Package Description:
10 SYRINGE in 1 CARTON / .5 mL in 1 SYRINGE (49281-722-88)
Product Code:
Proprietary Name:
Flublok Quadrivalent Northern Hemisphere
Non-Proprietary Name:
Influenza A Virus A/wisconsin/588/2019 (h1n1) Recombinant Hemagglutinin Antigen, Influenza A Virus A/darwin/6/2021 (h3n2) Recombinant Hemagglutinin Antigen, Influenza B Virus B/austria/1359417/2021 Recombinant Hemagglutinin Antigen, And Influenza B Virus B/phuket/3073/2013 Recombinant Hemagglutinin Antigen
Substance Name:
Influenza A Virus A/darwin/6/2021 (h3n2) Recombinant Hemagglutinin Antigen; Influenza A Virus A/wisconsin/588/2019 (h1n1) Recombinant Hemagglutinin Antigen; Influenza B Virus B/austria/1359417/2021 Recombinant Hemagglutinin Antigen; Influenza B Virus B/phuket/3073/2013 Recombinant Hemagglutinin Antigen
Usage Information:
Flublok Quadrivalent is a vaccine indicated for active immunization against disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Flublok Quadrivalent is approved for use in persons 18 years of age and older [see Clinical Studies (14)].
11-Digit NDC Billing Format:
49281072210
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2605564 - influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) 0.5 ML Prefilled Syringe
  • RxCUI: 2605564 - 0.5 ML influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe
  • RxCUI: 2605570 - FLUBLOK Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe
  • RxCUI: 2605570 - 0.5 ML influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2022-2023]
  • RxCUI: 2605570 - Flublok Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe
  • Product Type:
    Vaccine
    Labeler Name:
    Sanofi Pasteur Inc.
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Sample Package:
    No
    FDA Application Number:
    BLA125285
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    07-01-2022
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 49281-722-10 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    4928107221090682RIV4 VACC RECOMBINANT DNA IM0.5 ML0.510110

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 49281-722-10?

    The NDC Packaged Code 49281-722-10 is assigned to a package of 10 syringe in 1 carton / .5 ml in 1 syringe (49281-722-88) of Flublok Quadrivalent Northern Hemisphere, a vaccine label labeled by Sanofi Pasteur Inc.. The product's dosage form is injection and is administered via intramuscular form.

    Is NDC 49281-722 included in the NDC Directory?

    Yes, Flublok Quadrivalent Northern Hemisphere with product code 49281-722 is active and included in the NDC Directory. The product was first marketed by Sanofi Pasteur Inc. on July 01, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 49281-722-10?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 49281-722-10?

    The 11-digit format is 49281072210. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-249281-722-105-4-249281-0722-10